Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Bolla

Showing results (11-20 of 158) with videos related to

Pageof 16
Sort By:
European Urology|March 26, 2013
The potential impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomyMichel Bolla
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
Purification of Omp50, a minor porin of Campylobacter jejuniJean Michel Bolla
Lancet (London, England)|April 2, 2013
Postoperative radiotherapy for high-risk prostate cancer - Authors' replyMichel Bolla, Laurence Collette
Nature Reviews. Urology|December 16, 2015
Prostate cancer: Cardiac mortality associated with ADT plus radiotherapyMichel Bolla, Gilles Créhange
Nature Reviews. Urology|August 7, 2009
pT3N0M0 prostate cancer: a plea for adjuvant radiationMichel Bolla, Laurence Collette
Antibiotics (Basel, Switzerland)|June 27, 2024
RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative BacteriaMarine Novelli, Jean-Michel Bolla
Asian Journal of Urology|May 8, 2019
Prostate cancer: On the road of progressMichel Bolla, René-Olivier Mirimanoff
Future Medicinal Chemistry|December 16, 2014
Enhancing antibiotic activity to combat resistant Gram-negative bacteria: what's next?Jean Michel Bolla, Jean Michel Brunel
The New England Journal of Medicine|October 14, 2011
Radiotherapy and androgen deprivation for prostate cancerGilles Créhange, Michel Bolla, Philippe Maingon
Current Opinion in Urology|May 16, 2013
High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapyMichel Bolla, Camille Verry, Jean-Alexandre Long
Pageof 16

Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
European Urology|March 26, 2013
The potential impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomyMichel Bolla
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
Purification of Omp50, a minor porin of Campylobacter jejuniJean Michel Bolla
Lancet (London, England)|April 2, 2013
Postoperative radiotherapy for high-risk prostate cancer - Authors' replyMichel Bolla, Laurence Collette
Nature Reviews. Urology|December 16, 2015
Prostate cancer: Cardiac mortality associated with ADT plus radiotherapyMichel Bolla, Gilles Créhange
Nature Reviews. Urology|August 7, 2009
pT3N0M0 prostate cancer: a plea for adjuvant radiationMichel Bolla, Laurence Collette
Antibiotics (Basel, Switzerland)|June 27, 2024
RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative BacteriaMarine Novelli, Jean-Michel Bolla
Asian Journal of Urology|May 8, 2019
Prostate cancer: On the road of progressMichel Bolla, René-Olivier Mirimanoff
Future Medicinal Chemistry|December 16, 2014
Enhancing antibiotic activity to combat resistant Gram-negative bacteria: what's next?Jean Michel Bolla, Jean Michel Brunel
The New England Journal of Medicine|October 14, 2011
Radiotherapy and androgen deprivation for prostate cancerGilles Créhange, Michel Bolla, Philippe Maingon
Current Opinion in Urology|May 16, 2013
High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapyMichel Bolla, Camille Verry, Jean-Alexandre Long
Pageof 16